Biosensia

About:

Biosensia is a diagnostics company developing point-of-care platforms used for a variety of common biological sample types.

Website: http://www.biosensia.com

Twitter/X: biosensialtd

Top Investors: Enterprise Ireland, Atlantic Bridge, Seroba Life Sciences, Street Capital, Act Venture Capital

Description:

Biosensia is a Point-of-Care in-vitro diagnostics company that has a novel point-of-care platform, RapiPlex, available for licensing. RapiPlex combines highly innovative technologies to produce a practical, rapid, multiplexing POC in-vitro diagnostics (IVD) platform, enabling access to a broad range of diagnostic applications. Its component chip and cartridge system are compatible with a variety of common biological sample types, including whole blood, serum, saliva, urine and nasal/genital swabs.